CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Down 50.6% in February

CellaVision AB (publ) (OTCMKTS:CLVSF) saw a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 1,045 shares, a drop of 50.6% from the January 29th total of 2,116 shares. Based on an average daily volume of 112 shares, the short-interest ratio is currently 9.3 days. Based on an average daily volume of 112 shares, the short-interest ratio is currently 9.3 days.

CellaVision AB (publ) Price Performance

Shares of OTCMKTS:CLVSF remained flat at $15.85 during midday trading on Friday. CellaVision AB has a 12-month low of $16.69 and a 12-month high of $17.30. The company has a 50-day moving average of $16.64 and a two-hundred day moving average of $17.85.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.